Amgen Inc (AMGN)
313.71
+1.07
(+0.34%)
USD |
NASDAQ |
Mar 14, 16:00
313.54
-0.17
(-0.05%)
After-Hours: 20:00
Amgen Enterprise Value: 216.65B for March 14, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Gilead Sciences Inc | 153.84B |
| Johnson & Johnson | 404.46B |
| Eli Lilly and Co | 760.94B |
| Regeneron Pharmaceuticals Inc | 65.88B |
| Viking Therapeutics Inc | 2.565B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 627.00M |
| Revenue (Quarterly) | 9.086B |
| Total Expenses (Quarterly) | 6.775B |
| EPS Diluted (Quarterly) | 1.16 |
| Gross Profit Margin (Quarterly) | 65.75% |
| Profit Margin (Quarterly) | 6.90% |
| Earnings Yield | 2.41% |
| Operating Earnings Yield | 4.28% |
| Normalized Earnings Yield | 2.407 |